Approval · Notice of Compliance 4692 · 1996
Notice of Compliance 4692
Issued June 7, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4692
- Date
- June 7, 1996
- Company
- Du Pont Merck Pharma Inc.
- Product type
- Radiopharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in facility and manufacturing process
- Therapeutic class
- Radiodiagnostic agent
Products in this notice
None listed.